Citigroup (C)

Total Costs & Expenses

$16.51B

Quarterly · Period ending: · USD

C logo

C Total Costs & Expenses

Latest reported$16.51B
C Quarterly Total Costs & Expenses ($0.00 → $16.51B)
High-resolution chart · PNG

C total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Citigroup Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
16,506,000,000
37,273,000,000
36,918,000,000
36,843,000,000
38,495,000,000
37,126,000,000
35,807,000,000
37,098,000,000
38,969,000,000
38,328,000,000
39,178,000,000
43,498,000,000
35,960,000,000
34,145,000,000
30,269,000,000
27,263,000,000
20,846,000,000
17,265,000,000
16,202,000,000
14,382,000,000
13,554,000,000
12,386,000,000
11,397,000,000
14,079,000,000
16,185,000,000
22,135,000,000
23,518,000,000
19,224,000,000
20,090,000,000
20,355,000,000
19,881,000,000
18,671,000,000
18,653,000,000
18,409,000,000
17,942,000,000
16,692,000,000
16,795,000,000
16,625,000,000
15,951,000,000
15,189,000,000
15,314,000,000
14,898,000,000
15,508,000,000
16,549,000,000
15,446,000,000
15,627,000,000
15,827,000,000
19,598,000,000
18,030,000,000
20,866,000,000
17,714,000,000
18,102,000,000
17,590,000,000
18,331,000,000
19,077,000,000
21,672,000,000
19,738,000,000
20,033,000,000
20,928,000,000
21,797,000,000
21,842,000,000
22,761,000,000
21,563,000,000
22,200,000,000
23,622,000,000
24,960,000,000
26,427,000,000
27,040,000,000
28,311,000,000
31,517,000,000
29,649,000,000
48,683,000,000
35,800,000,000
35,665,000,000
37,749,000,000
44,067,000,000
39,462,000,000
36,495,000,000
36,147,000,000
32,387,000,000
29,000,000,000
28,334,000,000
27,198,000,000
24,491,000,000
23,995,000,000
21,927,000,000
21,021,000,000
21,127,000,000
17,356,000,000
24,993,000,000
17,406,000,000
17,468,000,000
16,435,000,000
17,585,000,000
17,177,000,000
19,163,000,000
17,901,000,000
17,755,000,000
17,291,000,000
20,877,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.